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Abstract
Objective: Resveratrol, a phytoalexin, has a wide range of desirable biological actions. 
Despite a growing body of evidence indicating that resveratrol induces changes in neu-
ronal function, little effort, if any, has been made to investigate the cellular effect of res-
veratrol treatment on intrinsic neuronal properties. 
Materials and Methods: This experimental study was performed to examine the 
acute effects of resveratrol (100 µM) on the intrinsic evoked responses of rat Cornu 
Ammonis (CA1) pyramidal neurons in brain slices, using whole cell patch clamp re-
cording under current clamp conditions.
Results: Findings showed that resveratrol treatment caused dramatic changes in 
evoked responses of pyramidal neurons. Its treatment induced a significant (P<0.05) 
increase in the after hyperpolarization amplitude of the first evoked action potential. 
Resveratrol-treated cells displayed a significantly broader action potential (AP) when 
compared with either control or vehicle-treated groups. In addition, the mean instanta-
neous firing frequency between the first two action potentials was significantly lower in 
resveratrol-treated neurons. It also caused a significant reduction in the time to maxi-
mum decay of AP. The rheobase current and the utilization time were both significantly 
greater following resveratrol treatment. Neurons exhibited a significantly depolarized 
voltage threshold when exposed to resveratrol.                 
Conclusion: Results provide direct electrophysiological evidence for the inhibitory 
effects of resveratrol on pyramidal neurons, at least in part, by reducing the evoked 
neural activity.  
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Introduction
In recent years, many naturally occurring com-
pounds consumed by human populations have 
gained considerable attention for the treatment 
of neurodegenerative diseases. In this context, 
resveratrol (3, 5, 4-trihydroxy-trans-stilbene), a 
phytoalexin produced by a variety of plant spe-
cies including grapes, mulberries, cranberries and 
peanuts has been shown to exert  a wide range of 
actions, including neuroprotective effects (1-4). In 
addition, it has been reported that resveratrol may 
have a potential role in the control of heart disease, 
atherosclerosis, arthritis, anti-aging, and autoim-
mune disorders (5-7).
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It has also been reported that it may reduce ex-
cite toxicity via an inhibitory effect on postsynap-
tic glutamatergic transmission and by enhancing 
glutamate uptake in astrocytes following oxida-
tive stress (8-10). Improvement of cognitive func-
tion by resveratrol treatment has been attributed 
to increasing insulin-like growth factor-I (IGF-I) 
production and promoting angiogenesis and neu-
rogenesis in the hippocampal astrocytes through 
stimulation of sensory neurons in the gastrointes-
tinal tract. It could also delay the onset of neuro-
degenerative disease and prevent learning impair-
ment in transgenic Alzheimer’s disease models 
(11-14).
In addition, resveratrol has a large attenuation 
effect on the increased spontaneous excitatory 
post synaptic currents (sEPSCs) in hippocampal 
pyramidal neurons (15). Chronic treatment with 
resveratrol could intensively inhibit the release 
of extracellular glutamate and aspartate during 
ischemia/reperfusion. Therefore, the neuroprotec-
tive effects of resveratrol may be partly due to its 
ability to attenuate extracellular excitotoxic gluta-
mate and aspartate accumulation (16). The inhibi-
tory effect of resveratrol on voltage-activated K+ 
currents in rat hippocampal neurons has also been 
suggested to be useful in treating ischemic brain 
injury (17).  The antinociceptive action of resvera-
trol in the formalin test has been found to be me-
diated by opening the Ca2+ activated-K+ channels 
(18).  In rat dorsal root ganglion, resveratrol sup-
pressed Na+ currents in a concentration-dependent 
manner (19). Its application can also reduce the 
frequency of seizures and improve the pathologi-
cal damage to hippocampal Cornu Ammonis (CA) 
CA1 and CA3 pyramidal neurons after kainic ac-
id-induced temporal lobe seizures (20).
These observations provide evidence that res-
veratrol can be applicable in protecting some ani-
mals suffering from different types of neurological 
disorders. However, despite extensive studies on 
the biological effects of resveratrol, little is known 
about its cellular mechanisms, including the actual 
electrophysiological actions on intrinsic neuronal 
evoked activity.
Considering the proved neuroprotective proper-
ties of resveratrol, therefore the main aim of this 
study was to determine the effects of resveratrol 
on evoked electrophysiological responses of CA1 
pyramidal neurons.
Materials and Methods
This experimental study was performed in ac-
cordance with the Ethical guidelines of Shahid Be-
heshti University of Medical Sciences and efforts 
were made to minimize animal suffering and the 
number of animals used. A total of 13 young adult 
male Wistar rats (4-6 weeks old were used and di-
vided into 3 groups: control (n=4 and 10 cells), ve-
hicle [dimethyl sulfoxide (DMSO)]-treated (n=4 
and 8 cells) and resveratrol-treated (n=5 and 12 
cells). They were kept at a room temperature of 23 
± 3˚C with a 12:12 hour light/dark cycle. Rats were 
given free access to rodent chow and tap water.
Hippocampal slice preparation and whole 
cell patch clamp recording 
Whole cell patch clamp recording was per-
formed as previously described (21, 22). Briefly, 
animals were anesthetized via inhalation of ether. 
They were then decapitated and their brains rapid-
ly removed and placed in ice-cold artificial-spinal 
fluid (ACSF) containing (in mM) 206 sucrose, 2.8 
KCl, 1 CaCl2, 1 MgCl2, 2 MgSO4, 1.25 NaH2PO4, 
26 NaHCO3, 10 D-glucose, and equilibrated to a 
pH=7.4 (with 95% O2 and 5% CO2); the osmolar-
ity was adjusted to 295 mOsm. All salts were pur-
chased from Sigma (UK). The hippocampus then 
was dissected out of the brain, and 300 µm thick 
transverse slices were obtained using a vibrating 
microtome (752 M, Campden Instruments Ltd., 
UK) before being transferred to an incubating 
chamber containing oxygenated ACSF (in mM): 2 
MgSO4, 2.8 KCl, 2 CaCl2, 124 NaCl, 1.25 NaH-
2PO4, 26 NaHCO3, 10 D-glucose, pH=7.4, 295 
mOsm, for at least 30 minutes at 32-35˚C. After 
incubation, slices were kept at room temperature 
(23-25˚C) until individually transferred into the 
recording chamber.
Intracellular whole-cell current-clamp recordings 
Hippocampal slices were transferred to a sub-
merged recording chamber on the stage of an up-
right microscope (Olympus, BX 51WI, Japan). 
CA1 pyramidal neurons were then visualized with 
a 60×water immersion objective using Nomarski-
type differential interference contrast imaging with 
infrared illumination. Images were captured with 
a CCDcamera (Hmamatsu, ORSA, Japan). The 
slices were continuously superfused with normal 
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oxygenated ACSF at room temperature (23-25˚C). 
Whole cell patch clamp recordings were obtained 
from hippocampal CA1 pyramidal neurons us-
ing Multiclamp 700 B amplifier, Digidata 1320 
A/D and pClamp 9.2 software (Axon Instruments, 
Molecular Devices Co., Sunnyvale, CA). Elec-
trophysiological responses were filtered at 5 kHz 
and sampled at 10 kHz and stored on a personal 
computer for offline analysis. Patch pipettes were 
pulled with a vertical microelectrode puller (PC10, 
Narishige, Tokyo, Japan) and had resistance of 4-7 
MΩ when filled with internal solution containing 
(in mM): 135 potassium methylsulfate (KMeSO4), 
10 KCl, 10 Hepes, 1 MgCl2, 2 Na2ATP, and 0.4 
Na2GTP. The pH of the internal solution was set 
to 7.3 by KOH and osmolarity was adjusted to 290 
mOsm. All salts were purchased from Sigma, UK.
To investigate the effect of resveratrol on the elec-
trically evoked responses, action potentials were 
elicited applying depolarizing current pulses (520 
mseconds) ranging from 100-500 pA in 100 pA in-
crements, in the presence of synaptic channel block-
ers (100 µM picrotoxin and 1 mM kynurenic acid, 
Sigma, UK). Alterations in evoked excitability was 
also examined using a depolarizing ramp current 
(880 mseconds) with a slope of 3.1 pA/ms from 0 
pA to 220 pA.
The following electrophysiological parameters 
were measured and assessed. The after hyperpo-
larization potential (AHP) amplitude was meas-
ured as the difference between the spike threshold 
and the minimum voltage following the AP peak. 
Action potential half width was measured at half 
amplitude of AP. Instantaneous firing frequency 
(1/interspike interval) was calculated from a train 
of AP evoked by pulses of 625 mseconds duration. 
Rheobase current and utilization time were de-
fined as the minimum current threshold required to 
evoke AP and the first spike latency during a ramp 
depolarizing current, respectively.
Drug application 
Resveratrol (Tocris, Bristol, UK) was dissolved in 
DMSO, to prepare a stock solution and was diluted 
to final concentration of 100 µM (9, 15, 19). The final 
concentration of DMSO was less than 0.1%. The re-
cording chamber with a volume of ~1.5 ml was con-
tinuously superfused with oxygenated ACSF at 1.5-2 
ml/minutes. Following the 8 minutes perfusion with 
ACSF containing resveratrol whole cell patch clamp 
recordings were done under current clamp condi-
tions. The entire recording period for each cell lasted 
approximately 25 minutes.
Cell selection criteria 
Patched CA1 pyramidal neurons were accepted 
for study if they had a patch seal resistance of 
greater than 1GΩ, a series resistance less than 20% 
of membrane resistance and a resting membrane 
potential between -55 to -65 mV. 
Data analysis 
The results obtained were expressed as mean ± 
standard error of mean (SEM). Statistical signifi-
cance was assessed by one-way ANOVA followed 
by Tukey’s post hoc test, using SPSS software 
(version 16). Values of P≤0.05 were considered to 
be significant.
Results
The effects of resveratrol (100 μM) on intrinsic 
evoked excitability were assessed after blocking syn-
aptic activities. Under current clamp conditions, de-
polarization of CA1 pyramidal neurons by injecting 
a series of current pulses with increasing amplitude 
led to a significant decrease in the instantaneous fir-
ing frequency in resveratrol-treated neurons when 
compared to either control or DMSO-treated neurons 
[F(2,15)=55.82, P<0.001; F(2,18)=8.41, P<0.05; 
F(2,18)=28.74, P<0.001; F(2,18)=17.36, P<0.001; 
F(2,14)=10.75, P<0.01, in response to 100 to 500 pA 
depolarizing current steps, respectively, Fig.1A-C]. In 
the presence of resveratrol, the number of evoked AP 
was also significantly decreased in response to a 500 
pA depolarizing current injection compared to con-
trol and vehicle treated groups (One way ANOVA, 
F(2,20)=3.68, P<0.05, Fig.1D).
In addition, comparison of the evoked action po-
tentials before and after application of resveratrol 
revealed a significantly larger AHP amplitude (One 
way ANOVA, F(2,17)=16.34, F(2,18)=18.98), 
F(2,19)=34.57 and  F(2,18)=24.93, in response to 
200, 300, 400 and 500 pA, respectively, P<0.001, 
Fig.2A, B).  Resveratrol treatment also caused a sig-
nificant prolongation of action potential duration at 
50% repolarization in response to higher depolarizing 
current injections (One way ANOVA, F(2,16)=5.86 
and F(2,14)=10.47, in response to 400 pA and 500 
pA current injections, respectively, Fig.2B, C).
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After the application of 100 μM resveratrol to 
the bath, depolarizing current injections resulted 
in a significant reduction in the time to max de-
cayslope of AP (One way ANOVA, F(2,11)=82.67, 
F(2,13)=38.78, F(2,13)=62.28, F(2,13)=66.55, 
F(2,11)=34.68, P<0.001, Fig.2C).
To further assess alteration of intrinsic neuronal 
excitability after resveratrol application, rheobase 
(threshold current), action potential voltage thresh-
old and utilization time were measured in response 
to a depolarizing current ramp from 0 pA to 220 
pA lasting 880 mseconds. (Fig.3A).
The average rheobase of CA1 pyramidal 
neurons was significantly higher after resveratrol 
treatment when compared to control and vehicle-
treated groups (One way ANOVA, F(2, 18)= 8.56, 
P<0.01, Fig.3B).
Addition of resveratrol to the ACSF led to a sig-
nificant increase in the utilization time (0.451 ± 
0.05 seconds) compared to control (0.220 ± 0.03 
seconds) and DMSO (0.238 ± 0.023 seconds) 
groups (One way ANOVA, F(2,20)=9.62, P<0.01, 
Fig.3C). The average AP voltage threshold was 
-43.45 ± 1.96 mV (P<0.05), after resveratrol 
application when compared to control (-50.07 
± 1.79 mV) and DMSO-treated (-51.67 ± 2.48 
mV) groups, respectively (One way ANOVA, 
F(2,19)=4.58, Fig.3D). There were no significant 
difference in the measured electrophysiological 
parameters between control and vehicle-treated 
neurons. 
Fig.1:  Suppressive effect of resveratrol on the evoked responses of CA1 pyramidal neurons representative membrane voltage responses 
to depolarizing current pulses of A. 100 pA, B. 500 pA before and after resveratrol treatment, C. The effect of resveratrol on the intrinsic 
firing frequency and D. The number of evoked spike per pulse.
CA; Cornu ammonis and DMSO; Dimethyl sulfoxide .
A B C
D
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Fig.2: Effect of resveratrol on evoked action potential parameters.
A. Histograms show the mean amplitude of after hyperpolarization potential (AHP). Superimposed traces of first evoked AP in 
response to 500 pA depolarizing current pulse recorded from control, dimethyl sulfoxide (DMSO)-treated and resveratrol treated 
neurons is shown in B. C. The mean half-width of action potential (AP) and D. The average time to maximum decay slope. *; 
Represents significant difference between control and resveratrol-treated groups (P<0.05) and †; Donates significant difference 
DMSO and resveratrol-treated groups (P<0.05).
A B
C D
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Fig.3: Effect of resveratrol on neuronal excitability.
A. Representative voltage responses to a depolarizing current ramp in control, B. Dimethyl sulfoxide (DMSO) -treated and C. Resveratrol-
treated groups, D. Histograms summarizing the effect of resveratrol on the rheobase current), utilization (latency to the first spike) and E. 
Voltage threshold compared to control and vehicle-treated neurons. *; Represents significant difference between control and resveratrol-
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Discussion
This study set out with the aim of assessing the 
acute electrophysiological effects of resveratrol on 
CA1 hippocampal pyramidal neurons. Here, the 
intrinsic evoked firing properties of CA1 pyrami-
dal neurons were investigated for the first time 
after blocking fast synaptic inputs. Several stud-
ies have provided evidence that resveratrol exerts 
neuroprotective activities (23-25).  However, very 
little is known about its effects on evoked electro-
physiological properties.
The findings of the present study revealed that 
extracellular application of resveratrol profoundly 
affected the evoked electrophysiological response 
properties of CA1 pyramidal neurons.
Resveratrol treatment produced a broader ac-
tion potential width and larger AHP amplitude 
which was associated with a lower neuronal ex-
citability.  The enhancement of the AHP ampli-
tude could be due to the larger Ca2+ entry allowed 
by the wider AP (26). It has been shown that the 
AHP is an intrinsic property of hippocampal py-
ramidal neurons and is caused by the contribution 
of Ca2+-dependent K+ current. There has been an 
increasing accumulation of evidence suggesting 
that resveratrol modulates the activities of several 
types of ion channels, such as stimulation of Ca2+-
activated K  (KCa2+) channels in vascular endothe-
lial cells, inhibition of L-type Ca2+ currents in ven-
tricular myocytes (15, 27), and inhibition of Na+ 
channel currents in rat dorsal root ganglion neu-
rons (19). It has been shown that the stimulatory 
effect of resveratrol on KCa2+ was associated with 
membrane hyperpolarization (28), which thereby 
may cause enhancement of AHP amplitude. Here, 
the large AHP amplitude observed in resveratrol-
treated neurons could be due to the activation of 
KCa2+ which was accompanied with a significant 
decrease in firing frequency.
The suppressive effect of resveratrol on neu-
ronal excitability observed in the present study 
is consistent with those of Li et al. (16, 29) who 
found that resveratrol inhibited the spontaneous 
discharge and ischemia-induced glutamate release 
in the rat hippocampal CA1 region. The present re-
sult is also consistent with Li et al. (28) who found 
resveratrol can significantly reduce epileptiform 
discharges induced by L-glutamate and reverse 
the increased discharges induced by Bay K8644 
which strongly suggests the inhibitory effects of 
resveratrol on voltage-gated L-type calcium chan-
nels. Suppression of voltage-dependent Ca2+ chan-
nel activity in rat cerebrocortical nerve terminals 
as a potential mechanism underlying the inhibi-
tion of glutamate release by resveratrol has also 
been reported (30). This also could be the reason 
for decreasing the neuronal excitability caused by 
resveratrol.
Acute exposures of CA1 pyramidal neurons to 
resveratrol also resulted in a significant increase in 
the rheobase current and utilization time and a sig-
nificant depolarized threshold voltage, which all 
contribute to the decreased neuronal excitability. 
Several factors including action potential thresh-
old and waveform may affect neuronal excitability 
(31). Modulation of voltage-gated Na+ channels 
regulates the depolarizing rising phase of action 
potential and firing frequency (32, 33). One pos-
sible explanation for the higher rheobase (thresh-
old) current and utilization time, and depolarized 
threshold voltage following resveratrol treatment 
could be due to a significant increase in the AHP 
amplitude, which in turn may lead to fewer Na+ 
channels available for activation.  The mechanism 
for the inhibitory effect of resveratrol on Na+ chan-
nels reported by Kim et al. (19) could also be the 
reason for the higher rheobase (threshold) current 
which reflects the lower excitability seen in neu-
rons treated with resveratrol in the present work.
Conclusion
The present results further characterized the 
electrophysiological consequences of the suppres-
sive effects of resveratrol on intrinsic neuronal 
excitability and electrical responsiveness in CA1 
pyramidal neurons. This suppressive action of res-
veratrol on intrinsic neuronal activity may be one 
of the underlying mechanisms for its neuroprotec-
tive effect against brain diseases which are associ-
ated with neuronal hyperexcitability.   
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